Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale
Identifieur interne : 000B33 ( Istex/Corpus ); précédent : 000B32; suivant : 000B34Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale
Auteurs : Kathy Dujardin ; Pascal Sockeel ; Anne-Sophie Carette ; Marie Delliaux ; Luc DefebvreSource :
- Movement Disorders [ 0885-3185 ] ; 2013-12.
Abstract
Apathy is an invalidating behavioral disorder that must always be screened for and assessed in patients with Parkinson's disease (PD). The Lille Apathy Rating Scale (LARS) has been validated in several different contexts, but the lengthy administration time means that it is mostly recommended for research use. The aim of the present study was to validate a short form of the LARS for use in everyday practice.
Url:
DOI: 10.1002/mds.25584
Links to Exploration step
ISTEX:FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38ABLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation><mods:affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: kathy.dujardin@univ-lille2.fr</mods:affiliation></affiliation></author><author><name sortKey="Sockeel, Pascal" sort="Sockeel, Pascal" uniqKey="Sockeel P" first="Pascal" last="Sockeel">Pascal Sockeel</name><affiliation><mods:affiliation>Laboratoire PSITEC, EA 4072, UDL3, Université Lille Nord de France, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Carette, Anne Ophie" sort="Carette, Anne Ophie" uniqKey="Carette A" first="Anne-Sophie" last="Carette">Anne-Sophie Carette</name><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Delliaux, Marie" sort="Delliaux, Marie" uniqKey="Delliaux M" first="Marie" last="Delliaux">Marie Delliaux</name><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><mods:affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1002/mds.25584</idno><idno type="url">https://api.istex.fr/document/FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000B33</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B33</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation><mods:affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: kathy.dujardin@univ-lille2.fr</mods:affiliation></affiliation></author><author><name sortKey="Sockeel, Pascal" sort="Sockeel, Pascal" uniqKey="Sockeel P" first="Pascal" last="Sockeel">Pascal Sockeel</name><affiliation><mods:affiliation>Laboratoire PSITEC, EA 4072, UDL3, Université Lille Nord de France, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Carette, Anne Ophie" sort="Carette, Anne Ophie" uniqKey="Carette A" first="Anne-Sophie" last="Carette">Anne-Sophie Carette</name><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Delliaux, Marie" sort="Delliaux, Marie" uniqKey="Delliaux M" first="Marie" last="Delliaux">Marie Delliaux</name><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><mods:affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</mods:affiliation></affiliation><affiliation><mods:affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-12">2013-12</date><biblScope unit="volume">28</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2014">2014</biblScope><biblScope unit="page" to="2019">2019</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB</idno><idno type="DOI">10.1002/mds.25584</idno><idno type="ArticleID">MDS25584</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Apathy is an invalidating behavioral disorder that must always be screened for and assessed in patients with Parkinson's disease (PD). The Lille Apathy Rating Scale (LARS) has been validated in several different contexts, but the lengthy administration time means that it is mostly recommended for research use. The aim of the present study was to validate a short form of the LARS for use in everyday practice.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Kathy Dujardin PhD</name><affiliations><json:string>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</json:string><json:string>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</json:string><json:string>E-mail: kathy.dujardin@univ-lille2.fr</json:string></affiliations></json:item><json:item><name>Pascal Sockeel PhD</name><affiliations><json:string>Laboratoire PSITEC, EA 4072, UDL3, Université Lille Nord de France, Lille, France</json:string></affiliations></json:item><json:item><name>Anne‐Sophie Carette MSc</name><affiliations><json:string>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</json:string></affiliations></json:item><json:item><name>Marie Delliaux MPsych</name><affiliations><json:string>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</json:string></affiliations></json:item><json:item><name>Luc Defebvre MD</name><affiliations><json:string>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</json:string><json:string>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>apathy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>short form</value></json:item></subject><articleId><json:string>MDS25584</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>shortCommunication</json:string></originalGenre><qualityIndicators><score>5.304</score><pdfVersion>1.4</pdfVersion><pdfPageSize>612 x 809.972 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>411</abstractCharCount><pdfWordCount>4000</pdfWordCount><pdfCharCount>25847</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>67</abstractWordCount></qualityIndicators><title>Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title><refBibs><json:item><author><json:item><name>D Aarsland</name></json:item><json:item><name>K Bronnick</name></json:item><json:item><name>U Ehrt</name></json:item></author><host><volume>78</volume><pages><last>42</last><first>36</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress</title></json:item><json:item><author><json:item><name>AF Leentjens</name></json:item><json:item><name>K Dujardin</name></json:item><json:item><name>L Marsh</name></json:item></author><host><volume>23</volume><pages><last>2014</last><first>2004</first></pages><author></author><title>Mov Disord</title></host><title>Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations</title></json:item><json:item><author><json:item><name>P Sockeel</name></json:item><json:item><name>K Dujardin</name></json:item><json:item><name>D Devos</name></json:item><json:item><name>C Deneve</name></json:item><json:item><name>A Destee</name></json:item><json:item><name>L Defebvre</name></json:item></author><host><volume>77</volume><pages><last>584</last><first>579</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease</title></json:item><json:item><author><json:item><name>P Robert</name></json:item><json:item><name>CU Onyike</name></json:item><json:item><name>AF Leentjens</name></json:item></author><host><volume>24</volume><pages><last>104</last><first>98</first></pages><author></author><title>Eur Psychiatry</title></host><title>Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders</title></json:item><json:item><author><json:item><name>E Mulin</name></json:item><json:item><name>E Leone</name></json:item><json:item><name>K Dujardin</name></json:item></author><host><volume>26</volume><pages><last>165</last><first>158</first></pages><author></author><title>Int J Geriatr Psychiatry</title></host><title>Diagnostic criteria for apathy in clinical practice</title></json:item><json:item><author><json:item><name>RL Drijgers</name></json:item><json:item><name>K Dujardin</name></json:item><json:item><name>JS Reijnders</name></json:item><json:item><name>L Defebvre</name></json:item><json:item><name>AF Leentjens</name></json:item></author><host><volume>16</volume><pages><last>660</last><first>656</first></pages><author></author><title>Parkinsonism Relat Disord</title></host><title>Validation of diagnostic criteria for apathy in Parkinson's disease</title></json:item><json:item><author><json:item><name>WR Gibb</name></json:item><json:item><name>AJ Lees</name></json:item></author><host><volume>51</volume><pages><last>752</last><first>745</first></pages><author></author><title>J Neurol Neurosurg Psychiatry</title></host><title>The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease</title></json:item><json:item><author><json:item><name>M Emre</name></json:item><json:item><name>D Aarsland</name></json:item><json:item><name>R Brown</name></json:item></author><host><volume>22</volume><pages><last>1707; 1837</last><first>1689</first></pages><author></author><title>Mov Disord</title></host><title>Clinical diagnostic criteria for dementia associated with Parkinson's disease</title></json:item><json:item><author><json:item><name>S Fahn</name></json:item><json:item><name>R Elton</name></json:item></author><host><pages><last>163</last><first>153</first></pages><author></author><title>Recent Developments in Parkinson's disease</title></host><title>UPDRS Development Committee Members. The Unified Parkinson's disease rating scale</title></json:item><json:item><author><json:item><name>SA Montgomery</name></json:item><json:item><name>M Asberg</name></json:item></author><host><volume>134</volume><pages><last>389</last><first>382</first></pages><author></author><title>Br J Psychiatry</title></host><title>A new depression scale designed to be sensitive to change</title></json:item><json:item><author><json:item><name>S Mattis</name></json:item></author><host><pages><last>121</last><first>77</first></pages><author></author><title>Geriatric Psychiatry</title></host><title>Mental status examination for organic mental syndrome in the elderly patient</title></json:item><json:item><author><json:item><name>WG Findley</name></json:item></author><host><volume>16</volume><pages><last>180</last><first>175</first></pages><author></author><title>Educ Psychol Meas</title></host><title>A rationale for evaluation of item discrimination statistics</title></json:item><json:item><author><json:item><name>RS Marin</name></json:item><json:item><name>RC Biedrzycki</name></json:item><json:item><name>S Firinciogullari</name></json:item></author><host><volume>38</volume><pages><last>162</last><first>143</first></pages><author></author><title>Psychiatry Res</title></host><title>Reliability and validity of the Apathy Evaluation Scale</title></json:item><json:item><author><json:item><name>K Dujardin</name></json:item><json:item><name>P Sockeel</name></json:item><json:item><name>M Delliaux</name></json:item><json:item><name>A Destee</name></json:item><json:item><name>L Defebvre</name></json:item></author><host><volume>23</volume><pages><last>849</last><first>845</first></pages><author></author><title>Mov Disord</title></host><title>The Lille Apathy Rating Scale: validation of a caregiver‐based version</title></json:item><json:item><author><json:item><name>JL Cummings</name></json:item><json:item><name>M Mega</name></json:item><json:item><name>K Gray</name></json:item><json:item><name>S Rosenberg‐Thompson</name></json:item><json:item><name>DA Carusi</name></json:item><json:item><name>J Gornbein</name></json:item></author><host><volume>44</volume><pages><last>2314</last><first>2308</first></pages><author></author><title>Neurology</title></host><title>The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia</title></json:item></refBibs><genre><json:string>brief-communication</json:string></genre><host><volume>28</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>5</total><last>2019</last><first>2014</first></pages><issn><json:string>0885-3185</json:string></issn><issue>14</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>clinical neurology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>neurology & neurosurgery</json:string></scienceMetrix></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1002/mds.25584</json:string></doi><id>FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB</id><score>0.19269168</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><availability><p>© 2013 Movement Disorder Society© 2013 Movement Disorder Society</p></availability><date>2013-06-21</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title><author xml:id="author-1"><persName><forename type="first">Kathy</forename><surname>Dujardin</surname></persName><roleName type="degree">PhD</roleName><email>kathy.dujardin@univ-lille2.fr</email><affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</affiliation><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation></author><author xml:id="author-2"><persName><forename type="first">Pascal</forename><surname>Sockeel</surname></persName><roleName type="degree">PhD</roleName><affiliation>Laboratoire PSITEC, EA 4072, UDL3, Université Lille Nord de France, Lille, France</affiliation></author><author xml:id="author-3"><persName><forename type="first">Anne‐Sophie</forename><surname>Carette</surname></persName><roleName type="degree">MSc</roleName><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation></author><author xml:id="author-4"><persName><forename type="first">Marie</forename><surname>Delliaux</surname></persName><roleName type="degree">MPsych</roleName><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation></author><author xml:id="author-5"><persName><forename type="first">Luc</forename><surname>Defebvre</surname></persName><roleName type="degree">MD</roleName><affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</affiliation><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-12"></date><biblScope unit="volume">28</biblScope><biblScope unit="issue">14</biblScope><biblScope unit="page" from="2014">2014</biblScope><biblScope unit="page" to="2019">2019</biblScope></imprint></monogr><idno type="istex">FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB</idno><idno type="DOI">10.1002/mds.25584</idno><idno type="ArticleID">MDS25584</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2013-06-21</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Apathy is an invalidating behavioral disorder that must always be screened for and assessed in patients with Parkinson's disease (PD). The Lille Apathy Rating Scale (LARS) has been validated in several different contexts, but the lengthy administration time means that it is mostly recommended for research use. The aim of the present study was to validate a short form of the LARS for use in everyday practice.</p></abstract><abstract><p>In total, 416 patients with PD and 56 healthy controls participated in the study. Apathy, depression, motor symptoms, and overall cognitive efficiency were assessed. The most discriminant items of the LARS for apathy detection were selected using multiple indicators.</p></abstract><abstract><p>A subset of 12 items (constituting the short‐form LARS) showed the best convergence. Concurrent and criterion‐related validity, internal consistency, test‐retest reliability, and inter‐rater reliability were very good.</p></abstract><abstract><p>The short‐form LARS is a reliable, practical, patient interview‐based instrument for assessing apathy in everyday clinical practice. © 2013 International Parkinson and Movement Disorder Society</p></abstract><textClass><keywords scheme="keyword"><list><head>keywords</head><item><term>apathy</term></item><item><term>Parkinson's disease</term></item><item><term>short form</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2013-04-09">Received</change><change when="2013-06-06">Registration</change><change when="2013-06-21">Created</change><change when="2013-12">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en" xml:id="mds25584"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="140"><doi>10.1002/mds.v28.14</doi><copyright ownership="thirdParty">© 2013 Movement Disorder Society</copyright><numberingGroup><numbering type="journalVolume" number="28">28</numbering><numbering type="journalIssue">14</numbering></numberingGroup><coverDate startDate="2013-12">December 2013</coverDate></publicationMeta><publicationMeta level="unit" position="220" type="shortCommunication" status="forIssue"><doi>10.1002/mds.25584</doi><idGroup><id type="unit" value="MDS25584"></id></idGroup><countGroup><count type="pageTotal" number="5"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">© 2013 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2013-04-09"></event><event type="manuscriptRevised" date="2013-05-20"></event><event type="manuscriptAccepted" date="2013-06-06"></event><event type="xmlCreated" agent="Cenveo Publisher Services" date="2013-06-21"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.2.7 mode:FullText" date="2013-12-09"></event><event type="publishedOnlineEarlyUnpaginated" date="2013-07-08"></event><event type="firstOnline" date="2013-07-08"></event><event type="publishedOnlineFinalForm" date="2013-12-09"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-01"></event></eventGroup><numberingGroup><numbering type="pageFirst">2014</numbering><numbering type="pageLast">2019</numbering></numberingGroup><correspondenceTo><b>Correspondence to:</b> Dr. Kathy Dujardin, Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, F‐59037 Lille Cedex, France; <email>kathy.dujardin@univ-lille2.fr</email></correspondenceTo><objectNameGroup><objectName elementName="appendix">Appendix</objectName></objectNameGroup><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS25584.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title><title type="short">Assessing Apathy in PD</title><title type="shortAuthors">Dujardin et al.</title></titleGroup><creators><creator affiliationRef="#mds25584-aff-0001 #mds25584-aff-0002" corresponding="yes" creatorRole="author" xml:id="mds25584-cr-0001"><personName><givenNames>Kathy</givenNames> <familyName>Dujardin</familyName><degrees>PhD</degrees></personName></creator><creator affiliationRef="#mds25584-aff-0003" creatorRole="author" xml:id="mds25584-cr-0002"><personName><givenNames>Pascal</givenNames> <familyName>Sockeel</familyName><degrees>PhD</degrees></personName></creator><creator affiliationRef="#mds25584-aff-0002" creatorRole="author" xml:id="mds25584-cr-0003"><personName><givenNames>Anne‐Sophie</givenNames> <familyName>Carette</familyName><degrees>MSc</degrees></personName></creator><creator affiliationRef="#mds25584-aff-0002" creatorRole="author" xml:id="mds25584-cr-0004"><personName><givenNames>Marie</givenNames> <familyName>Delliaux</familyName><degrees>MPsych</degrees></personName></creator><creator affiliationRef="#mds25584-aff-0001 #mds25584-aff-0002" creatorRole="author" xml:id="mds25584-cr-0005"><personName><givenNames>Luc</givenNames> <familyName>Defebvre</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation countryCode="FR" type="organization" xml:id="mds25584-aff-0001"><orgDiv>Laboratoire de Neurosciences Fonctionnelles et Pathologies</orgDiv><orgDiv>EA 4559</orgDiv><orgName>Université Lille</orgName><address><city>Lille</city><country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="mds25584-aff-0002"><orgDiv>Neurologie et Pathologie du Mouvement</orgDiv><orgDiv>Neurologie A</orgDiv><orgDiv>Hôpital Salengro</orgDiv><orgName>Centre Hospitalier Universitaire</orgName><address><city>Lille</city><country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="mds25584-aff-0003"><orgDiv>Laboratoire PSITEC</orgDiv><orgDiv>EA 4072</orgDiv><orgDiv>UDL3</orgDiv><orgName>Université Lille Nord de France</orgName><address><city>Lille</city><country>France</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="mds25584-kwd-0001">apathy</keyword><keyword xml:id="mds25584-kwd-0002">Parkinson's disease</keyword><keyword xml:id="mds25584-kwd-0003">short form</keyword></keywordGroup><abstractGroup><abstract type="main"><title type="main">ABSTRACT</title><section xml:id="mds25584-sec-0001"><title type="main">Background</title><p>Apathy is an invalidating behavioral disorder that must always be screened for and assessed in patients with Parkinson's disease (PD). The Lille Apathy Rating Scale (LARS) has been validated in several different contexts, but the lengthy administration time means that it is mostly recommended for research use. The aim of the present study was to validate a short form of the LARS for use in everyday practice.</p></section><section xml:id="mds25584-sec-0002"><title type="main">Methods</title><p>In total, 416 patients with PD and 56 healthy controls participated in the study. Apathy, depression, motor symptoms, and overall cognitive efficiency were assessed. The most discriminant items of the LARS for apathy detection were selected using multiple indicators.</p></section><section xml:id="mds25584-sec-0003"><title type="main">Results</title><p>A subset of 12 items (constituting the short‐form LARS) showed the best convergence. Concurrent and criterion‐related validity, internal consistency, test‐retest reliability, and inter‐rater reliability were very good.</p></section><section xml:id="mds25584-sec-0004"><title type="main">Conclusions</title><p>The short‐form LARS is a reliable, practical, patient interview‐based instrument for assessing apathy in everyday clinical practice. © 2013 International Parkinson and Movement Disorder Society</p></section></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="mds25584-note-0001"><p><b>Relevant conflicts of interest/financial disclosures:</b> Nothing to report.</p></note><note xml:id="mds25584-note-0002"><p>Full financial disclosures and author roles may be found in the online version of this article.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Assessing Apathy in PD</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale</title></titleInfo><name type="personal"><namePart type="given">Kathy</namePart><namePart type="family">Dujardin</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</affiliation><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation><affiliation>E-mail: kathy.dujardin@univ-lille2.fr</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Pascal</namePart><namePart type="family">Sockeel</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Laboratoire PSITEC, EA 4072, UDL3, Université Lille Nord de France, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Anne‐Sophie</namePart><namePart type="family">Carette</namePart><namePart type="termsOfAddress">MSc</namePart><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Marie</namePart><namePart type="family">Delliaux</namePart><namePart type="termsOfAddress">MPsych</namePart><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Luc</namePart><namePart type="family">Defebvre</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Laboratoire de Neurosciences Fonctionnelles et Pathologies, EA 4559, Université Lille, Lille, France</affiliation><affiliation>Neurologie et Pathologie du Mouvement, Neurologie A, Hôpital Salengro, Centre Hospitalier Universitaire, Lille, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief-communication" displayLabel="shortCommunication"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2013-12</dateIssued><dateCreated encoding="w3cdtf">2013-06-21</dateCreated><dateCaptured encoding="w3cdtf">2013-04-09</dateCaptured><dateValid encoding="w3cdtf">2013-06-06</dateValid><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract>Apathy is an invalidating behavioral disorder that must always be screened for and assessed in patients with Parkinson's disease (PD). The Lille Apathy Rating Scale (LARS) has been validated in several different contexts, but the lengthy administration time means that it is mostly recommended for research use. The aim of the present study was to validate a short form of the LARS for use in everyday practice.</abstract><abstract>In total, 416 patients with PD and 56 healthy controls participated in the study. Apathy, depression, motor symptoms, and overall cognitive efficiency were assessed. The most discriminant items of the LARS for apathy detection were selected using multiple indicators.</abstract><abstract>A subset of 12 items (constituting the short‐form LARS) showed the best convergence. Concurrent and criterion‐related validity, internal consistency, test‐retest reliability, and inter‐rater reliability were very good.</abstract><abstract>The short‐form LARS is a reliable, practical, patient interview‐based instrument for assessing apathy in everyday clinical practice. © 2013 International Parkinson and Movement Disorder Society</abstract><subject><genre>keywords</genre><topic>apathy</topic><topic>Parkinson's disease</topic><topic>short form</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov Disord.</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><detail type="issue"><caption>no.</caption><number>14</number></detail><extent unit="pages"><start>2014</start><end>2019</end><total>5</total></extent></part></relatedItem><identifier type="istex">FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB</identifier><identifier type="DOI">10.1002/mds.25584</identifier><identifier type="ArticleID">MDS25584</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2013 Movement Disorder Society© 2013 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B33 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B33 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:FDF9D83A54FB3DE34FDEC74AF7BD14DE8D9E38AB
|texte= Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale
}}
| This area was generated with Dilib version V0.6.29. |  |